1 completed, 1 terminated, 1 withdrawn. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Mucous Membrane Pemphigoid: new trials by email Literature Review of Mucous Membrane Pemphigoid trials Research Report on Mucous Membrane Pemphigoid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Baricitinib for the Treatment of Ocular Mucous Membrane Pemphigoid Baricitinib 2 MG [Olumiant], Methotrexate, Azathioprine - Mucous Membrane Pemphigoid, Cicatrizing Conjunctivitis | Phase 2 | Terminated | Washington University School of Medicine | 2 | 2022-02-21 | 2023-11-07 |
| Dexamethasone Solution and Dexamethasone in Mucolox™ dexamethasone 0.5mg/5ml solution, dexamethasone 0.5mg/5ml solution in Mucolox™ - Oral Lichen Planus, Mucous Membrane Pemphigoid | Phase 2 | Completed | University of California, San Francisco | 29 | 2020-12-26 | 2023-12-15 |
| Topical Infliximab in Autoimmune Eyes With Keratoprosthesis topical infliximab - Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis (Lyell) Syndrome | Phase 1 / Phase 2 | Withdrawn | James Chodosh, MD, MPH | 2014-11-01 | 2017-04-07 |
Pemphigoid, Benign Mucous Membrane (3) · Bronchiolitis Obliterans Syndrome (1) · Lichen Planus, Oral (1) · Pemphigus (1) · Stevens-Johnson Syndrome (1) · Syndrome (1)
Conjunctival Diseases (3) · Eye Diseases (3) · Skin Diseases (3) · Skin Diseases, Vesiculobullous (3) · Skin and Connective Tissue Diseases (3) · Immune System Diseases (2) · Mouth Diseases (2) · Stomatognathic Diseases (2) · Autoimmune Diseases (1) · Bronchial Diseases (1) · Bronchiolitis (1) · Bronchiolitis Obliterans (1) · Bronchitis (1) · Chemically-Induced Disorders (1) · Dermatitis (1)
Azathioprine (1) · Dexamethasone (1) · Infliximab (1) · Methotrexate (1) · Mycophenolic Acid (1) · Solutions (1) · baricitinib (1)
James Chodosh, MD, MPH (1) · University of California, San Francisco (1) · Washington University School of Medicine (1)
United States (3) · Canada (1)
Alessandro Villa, DDS, PhD, MPH (1) · Claes H Dohlman, MD, PhD (1) · James Chodosh, MD, MPH (1) · Mona Harissi-Dagher, MD (1)